Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: LLGM who wrote (76)	12/26/2001 9:01:56 AM
From: Arthur Radley	Respond to of 1590

My apology to all our Canadian friends, but AXCA is a sleeping biotech because they are domiciled in Canada. If they were a US company they would get the proper respect they deserve. Helicide should get FDA approval in 2002 and should get gold standard labeling for h pylori treatment. Just got through reading an article in today's paper about the growing nature of this disease and other gastro diseases. They have a nice niche and growing profits...not something that many biotechs can say....